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INTRODUCTION
Pyonephrosis is a potentially fatal condition in which
infection occurs in an obstructed collecting system,
resulting in gross accumulation of pus. The resulting
septicaemia and possible septicaemic shock can be life
threatening, especially in patients with underlying pre-
morbid medical conditions. Although potent intravenous
antibiotics are effective in some cases, urgent de-
compression of the collecting system often is required
upon failure of medical treatment. Percutaneous
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nephrostomy (PCN) for drainage of pyonephrosis
was first described in 19761 and has since gained
wide acceptance. In light of the availability of
modern broad-spectrum antibiotics and improved
diagnostic imaging, the role of PCN is revisited. The
purpose of this study was to evaluate the efficacy of
PCN for the management of pyonephrosis, and to
study the causative microorganisms and the use of
PCN cultures in the selection of antibiotic therapy.
MATERIALS AND METHODS
From January 1996 to December 1999, the
records of 92 consecutive patients (29 men and 63
women; mean age, 57 years; range, 23–88 years)
who underwent PCN for the treatment of
pyonephrosis were reviewed retrospectively.
Pyonephrosis was defined by the following clinical
criteria: 1) systemic symptoms and signs suggestive
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of upper urinary tract infection, supported by abnormal
laboratory findings including pyuria, 2) elevated white
blood cell count, 3) elevated serum creatinine, 4)
radiological findings of hydronephrosis on ultrasonography
or computed tomography and 5) the confirmatory finding
of turbid urine or pus on the initial percutaneous aspirate.
Only patients with positive aspirate were deemed to have
pyonephrosis. Certain ultrasonographic criteria for
distinguishing pyonephrosis from simple hydronephrosis,
such as persistent dependent echoes and shifting urine-
debris level were useful adjuncts to the clinical diagnosis.
Patients who underwent percutaneous drainage for renal
or perinephric abscess were excluded from this study.
PCN for the relief of obstructive uropathy from malignant
conditions was excluded from our study if there was no
evidence of pyonephrosis.
The indication for PCN was failure of sepsis resolution
despite adequate medical treatment. The decision and
exact timing for PCN was based on the individual
physician’s judgement. In general, persistent fever, loin
pain, vomiting or lethargy, and failure to show
improvement of condition within 24–48 hours after
admission were taken as failed medical treatment. Patients
with haemodynamic disturbances and those with multiple
medical co-morbidities were offered intervention early.
PCN was performed under fluoroscopic or ultrasound
guidance according to the preference and experience of
the interventional radiologist. There was a tendency to
utilize ultrasound in minimally-dilated pelvi-calyceal
systems. Bedside ultrasound-guided puncture was also
utilized for occasional patients who were severely toxic
and staying in the intensive care unit. The puncture
technique involved the use of a 19G sheathed needle or
22G Chiba needle for initial puncture and for aspiration
of pus for culture. Subsequently, a self-retaining Cope
loop nephrostomy catheter (Cook, Queensland, Australia)
was inserted for drainage. After the initial PCN, an
antegrade nephrostogram was performed between 48
and 72 hours to delineate the exact nature of the obstruction
and configuration of the urinary tract.
All medical records were reviewed for aetiology, clinical
presentation, laboratory and microbiological culture reports,
definitive treatment, complications and patient outcome.
RESULTS
The most common pre-existing medical conditions
were diabetes (83%), hypertension (37%), history of
previous urinary calculi (26%), ischaemic heart disease
(9%) and history of hydronephrosis (7%). The presenting
symptoms were fever (89%), abdominal or loin pain
(77%), vomiting (23%), dysuria (14%) and haematuria
(2%). Septicaemic shock was present in 11% of patients,
acute renal failure in 2% and pulmonary oedema in 1%
at first presentation.
Analysis of basic investigations showed that 47% of
the patients had a total white cell count of ≥ 15,000 /ml.
Fifty-five percent of patients had an increased serum
creatinine of ≥ 141 mmol/L. Eighty-eight percent of patients
had greater than five white blood cells per high-power
field on urinalysis.
The commonly employed diagnostic imaging
modalities were ultrasonography (75%), computed
tomography (25%), intravenous urography (9%), and
retrograde pyelography (2%).
Ureteric obstruction was caused by urinary calculi in
77% of patients. Less common causes were benign stricture
(9%), papillary necrosis (7%), pelvi-ureteric junction
obstruction (4%) and malignant stricture (3%).
Analysis of cultures from PCN, bladder urine and
blood showed that 65 patients (70%) had positive cultures
from at least one specimen, and seven patients (8%) had
more than one organism isolated. Overall, the most
common microorganisms isolated were E. coli (30%),
Klebsiella (19%), Proteus (8%), Pseudomonas (5%),
Enterococcus (5%) and Candida supp(5%) (Table 1).
The common antibiotics to which the microorganisms
were sensitive included gentamicin (79%), ceftriaxone
(71%), cephalexin (54%), nitrofurantoin (40%),
cotrimoxazole (35%), nalidixic acid (32%) and ampicillin
(29%) (Table 2). Sensitivity to ciprofloxacin was not
routinely tested. For bladder urine alone, 30% of cultures
were positive for microorganisms. Diagnostic yield was
improved by factoring in the results of PCN cultures and
blood cultures (Table 3). For patients who had both
bladder urine and PCN cultures, 58% had either culture
positive. For patients who had bladder urine,
blood and PCN cultures performed, the positive rate was
71%.
The results of bladder urine and blood culture did not
necessarily correlate with PCN cultures. In patients who
had both bladder urine and PCN urine aspirate sent for
bacteriology, the cultures were identical in only 27%. In
51% of cases, bladder urine culture was negative, while
PCN aspirate culture was positive. Likewise, in patients
who had both blood and PCN cultures, the cultures
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Table 1. Organisms grown from percutaneous nephrostomy (PCN) aspirate, bladder urine, blood cultures and overall
culture positive rate from any one of the specimens
PCN (%) Bladder urine (%) Blood (%) Overall (%)
Number of cultures 73 83 86 92
Number of positive cultures* 37 (51) 25 (30) 37 (43) 65 (70)
Escherichia coli 16 (21) 9 (11) 17 (20) 28 (30)
Klebsiella spp 7 (10) 2 (2) 6 (7) 12 (19)
Proteus spp 3 (4) 1 (1) 6 (7) 9 (8)
Pseudomonas spp 5 (7) 1 (1) – 5 (5)
Enterococcus spp 4 (6) 1 (1) – 5 (5)
Candida spp 3 (4) 5 (6) 2 (2) 5 (5)
Staphylococcus spp 1 (1) 1 (1) 2 (2) 3 (3)
Citrobacter spp 2 (3) 2 (2) 1 (1) 2 (2)
Gram negative bacillus 1 (1) 1 (1) 1 (1) 2 (2)
Acinetobacter spp – 1 (1) 1 (1) 2 (2)
Group D Streptococcus 1 (1) 1 (1) 1 (1) 1 (1)
Group B Streptococcus – 1 (1) – 1 (1)
Enterobacter spp – 1 (1) – 1 (1)
Bacillus spp – – 1 (1) 1 (1)
*Patients with multiple organisms counted as one event.
were identical in only 24%. In 46% of cases, blood
cultures were negative, while PCN cultures were positive
(Table 4).
Based on the culture results, the empirical broad-
spectrum antibiotic regime was modified. The antibiotics
used for definitive treatment were ceftriaxone (70%),
gentamicin (14%) and ciprofloxacin (12%).
Sixty-nine percent of patients had minimally invasive
procedures performed as definitive treatment after PCN.
These procedures included extracorporeal shockwave
lithotripsy (24%), percutaneous nephrolithotripsy (15%),
ureteric stenting (12%), ureteroscopic lithotripsy (10%),
endopyelotomy (1%) and combined procedures (7%).
Open surgery was performed in 14% of patients. The
procedures included nephrectomy (12%), uretero-
lithotomy (1%) and ileal loop replacement (1%). The
remaining 17% of patients did not undergo any intervention
after PCN. The reasons included spontaneous resolution
of obstruction (passage of stone or sloughed papillae); or
the patient was deemed unfit for surgery, refused surgery,
was lost to follow-up or died (n = 2).
 Specific complications related to PCN were
uncommon, but included slipped catheter (8%), minor
haemorrhage (2%), wound infection (2%) and
Table 2. Antibiogram of microorganisms to commonly prescribed first-line antibiotics
Antibiotic Escherichia coli Klebsiella Proteus Pseudomonas Enterococcus Staphylococcus
spp spp spp spp spp
Ceftriaxone 90 83 82 25
Gentamicin 93 92 82 75 50
Cephalexin 38 83 64 25 75
Ampicillin 13 64 25 100 25
Cotrimoxazole 30 42 25 75
Nalidixic acid 28 42 27
Nitrofurantoin 35 50 25 100
Values are given as percentage of microorganisms sensitive to listed antibiotics.
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for anatomical evaluation and delineation of the
obstructing lesion. With the advent of percutaneous
endoscopic techniques, PCN can serve as an access for
subsequent definitive procedures. Where indicated, PCN
facilitates differential renal function studies and intrarenal
pressure measurement as in the standard Whitaker test.
Finally, direct irrigation with saline, antibiotics and
antifungals is possible with the PCN in situ.5
Comparisons have been made between decompression
using PCN and ureteral stenting for the interim treatment
of pyonephrosis.6,7 Pearle et al attempted to address the
issue of the optimal route of urgent decompression in a
small randomized study comprising 42 patients.7 They
found that both the percutaneous route and the retrograde
route were effective. However, 62% of PCN urine cultures
were positive compared with only 19% of retrograde
catheter urine cultures. At our institution, ureteral stenting
for urgent decompression for pyonephrosis is not routine
practice. This is because we believe that retrograde ureteral
stenting has a number of disadvantages in the management
of pyonephrosis compared with PCN. Firstly, the ureteric
stent usually comes in smaller sizes, which provides less
effective drainage. Secondly, ureteral stenting often needs
to be performed in the operating room under general
anaesthesia. Furthermore, there is the risk of perforating
the ureter during manipulation. In addition, bacteraemia
and septicaemia may flare up under the pressure of the
irrigation fluid.
On the other hand, a distinct advantage of PCN is that
nephrostomy cultures provide microbiological information
that is not available in bladder urine cultures.5,8 It was
demonstrated in our study that the percentage of successful
isolation of organisms in cultures increased when PCN
cultures were included (Table 3). The pick-up rate from
bladder urine cultures, combined bladder urine and
nephrostomy cultures, and combined bladder urine, blood
Table 3. Incidence of positive cultures from different
specimens
Available specimen Positive cultures (%)
Bladder urine 25/83 (30)
Blood 37/86 (43)
PCN 37/73 (51)
Bladder urine + PCN 37/64 (58)
Bladder urine + blood 45/77 (58)
Blood + PCN 46/68 (68)
Bladder urine + blood +  PCN 42/59 (71)
PCN =  percutaneous nephrostomy aspirate.
Table 4. Matching of percutaneous nephrostomy aspirate, bladder urine and blood cultures
PCN and bladder urine Frequency Percentage PCN and blood Frequency Percentage
Identical 10 27 Identical 11 24
Different 4 11 Different 2 4
PCN +ve, bladder urine –ve 19 51 PCN +, blood – 21 46
PCN –ve, bladder urine +ve 4 11 PCN –, blood + 12 26
Total 37 100 Total 46 100
PCN =  percutaneous nephrostomy aspirate; + = positive; – = negative.
extravasation (1%). The mortality rate was 2%, due to
septicaemic shock in one patient and pneumonia in
another.
DISCUSSION
Barbaric et al first described PCN for drainage of
pyonephrosis in 1976.1 Subsequently, Lang and Price
demonstrated that PCN for obstructed renal systems
achieved rapid control of infections and decreased
mortality from gram-negative septicaemia (7%), compared
to treatment with antibiotics and steroids alone (40%) or
surgical decompression (13%).2 Other authors reported
on the advantages of PCN.3–5 Firstly, the procedure can be
done under local anaesthesia. Secondly, evacuation of
pus and necrotic material reduces bacterial burden.3 In
addition, decompressing the collecting system improves
renal perfusion and function, and hence, the entry of
antibiotics into the renal parenchyma.4 Sufficient control
of sepsis and return of renal function can be achieved and
nephrectomy can be avoided.3,5 Upon control of the
initial sepsis, PCN allows follow-up antegrade pyelography
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that is not available from bladder urine or blood cultures,
and allows selection of appropriate antibiotic therapy.
The procedure often allows the kidney to be salvaged and
facilitates subsequent definitive procedures. PCN is
associated with minor morbidity, provides therapeutic
benefit and is the recommended treatment for pyonephrosis
after failed medical therapy.
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and nephrostomy cultures were 30%, 58% and 71%,
respectively. Studies also showed that the disparity between
bladder urine cultures and PCN cultures ranged from 37%
to 52%.3,8 This disparity was reflected in our study. The
reason for the poor correlation between PCN and bladder
urine cultures could be because complete ureteric obstruction
often prevents microorganisms from travelling from the
upper tract down to the bladder. In addition, antibiotics may
inhibit bladder urine and blood culture growth despite
significant infection in an obstructed kidney. The ability to
identify the causative microorganism from PCN cultures is
a major advantage, because appropriate antibiotics can
be instituted instead of depending on empirical therapy.
PCN has made it possible to address acute urinary
obstructions before proceeding to definitive surgical
treatment. With improved diagnosis, early intervention
by PCN and widespread use of endourological techniques,
many patients are spared open surgery. Nephrectomy is
now only indicated if the kidney is deemed non-functioning
after adequate decompression by PCN and split creatinine
clearance studies. In our study, the nephrectomy rate was
12%. This is a significant improvement from earlier studies,
where the nephrectomy rates ranged from 35% to 88%.8–11
Eleven percent of patients developed septicaemic
shock prior to PCN. This was a reflection of the potential
hazard of pyonephrosis. In our study, the complications
related to the procedure itself were uncommon and minor.
With timely intervention, the mortality rate was decreased
to a minimum of 2% for this life-threatening condition.
CONCLUSION
PCN is an important measure for interim management
of pyonephrosis. PCN cultures yield valuable information
